Dr. Theodore Kurtz, M.D
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $13,750 | 2 | 35.3% |
| Travel and Lodging | $12,130 | 5 | 31.2% |
| Consulting Fee | $8,319 | 1 | 21.4% |
| Unspecified | $4,126 | 1 | 10.6% |
| Food and Beverage | $611.96 | 8 | 1.6% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nippon Boehringer Ingelheim Co., Ltd. | $17,864 | 8 | $0 (2017) |
| Amgen Inc. | $8,319 | 1 | $0 (2017) |
| Boehringer Ingelheim Mexico SA de CV | $8,060 | 3 | $0 (2017) |
| Midmark Corporation | $4,464 | 3 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $167.65 | 1 | $0 (2017) |
| Microgenics Corporation | $63.39 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $63.39 | 1 | Microgenics Corporation ($63.39) |
| 2017 | $38,874 | 16 | Nippon Boehringer Ingelheim Co., Ltd. ($17,864) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2018 | Microgenics Corporation | Procalcitonin (PCT) (Device) | Food and Beverage | Cash or cash equivalent | $63.39 | General |
| Category: Biomarkers | ||||||
| 11/29/2017 | Boehringer Ingelheim Mexico SA de CV | MICARDIS (Drug) | Travel and Lodging | In-kind items and services | $1,323.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/27/2017 | Boehringer Ingelheim Mexico SA de CV | MICARDIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,000.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/17/2017 | Nippon Boehringer Ingelheim Co., Ltd. | MICARDIS (Drug) | Travel and Lodging | In-kind items and services | $8,626.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/17/2017 | Nippon Boehringer Ingelheim Co., Ltd. | MICARDIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,750.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/17/2017 | Nippon Boehringer Ingelheim Co., Ltd. | MICARDIS (Drug) | Travel and Lodging | In-kind items and services | $1,228.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2017 | Amgen Inc. | Repatha (Biological) | Consulting Fee | Cash or cash equivalent | $8,319.13 | General |
| Category: Cardiology | ||||||
| 11/01/2017 | Boehringer Ingelheim Mexico SA de CV | MICARDIS (Drug) | Travel and Lodging | In-kind items and services | $736.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/22/2017 | Nippon Boehringer Ingelheim Co., Ltd. | MICARDIS (Drug) | Food and Beverage | In-kind items and services | $66.37 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/21/2017 | Nippon Boehringer Ingelheim Co., Ltd. | MICARDIS (Drug) | Food and Beverage | In-kind items and services | $84.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/20/2017 | Nippon Boehringer Ingelheim Co., Ltd. | MICARDIS (Drug) | Food and Beverage | In-kind items and services | $7.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/19/2017 | Nippon Boehringer Ingelheim Co., Ltd. | MICARDIS (Drug) | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/18/2017 | Nippon Boehringer Ingelheim Co., Ltd. | MICARDIS (Drug) | Food and Beverage | In-kind items and services | $89.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/16/2017 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $167.65 | General |
| 06/22/2017 | Midmark Corporation | — | — | Cash or cash equivalent | $4,126.08 | Research |
| 06/22/2017 | Midmark Corporation | — | Travel and Lodging | In-kind items and services | $215.46 | General |
| 06/22/2017 | Midmark Corporation | — | Food and Beverage | In-kind items and services | $122.25 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 4,889 | 11,874 | $2.3M | $179,647 |
| 2022 | 5 | 4,341 | 10,533 | $1.9M | $159,659 |
| 2021 | 5 | 4,065 | 9,782 | $1.8M | $152,165 |
| 2020 | 5 | 3,262 | 8,202 | $1.4M | $130,180 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 84165 | Protein measurement, serum | Facility | 2023 | 2,138 | 5,494 | $1.1M | $82,765 | 7.7% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Facility | 2023 | 1,627 | 4,596 | $937,965 | $69,640 | 7.4% |
| 84166 | Protein measurement, body fluid | Facility | 2023 | 651 | 1,058 | $163,990 | $16,110 | 9.8% |
| 86335 | Immunologic analysis technique on body fluid, other fluids with concentration | Facility | 2023 | 377 | 627 | $126,318 | $9,626 | 7.6% |
| 83020 | Hemoglobin analysis and measurement, electrophoresis | Facility | 2023 | 96 | 99 | $19,058 | $1,507 | 7.9% |
| 84165 | Protein measurement, serum | Facility | 2022 | 1,970 | 5,004 | $910,728 | $75,422 | 8.3% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Facility | 2022 | 1,397 | 4,111 | $785,201 | $62,431 | 8.0% |
| 84166 | Protein measurement, body fluid | Facility | 2022 | 566 | 815 | $126,325 | $12,537 | 9.9% |
| 86335 | Immunologic analysis technique on body fluid, other fluids with concentration | Facility | 2022 | 311 | 496 | $94,736 | $7,613 | 8.0% |
| 83020 | Hemoglobin analysis and measurement, electrophoresis | Facility | 2022 | 97 | 107 | $19,474 | $1,655 | 8.5% |
| 84165 | Protein measurement, serum | Facility | 2021 | 1,840 | 4,630 | $842,660 | $71,398 | 8.5% |
| 86334 | Immunologic analysis technique on serum (immunofixation) | Facility | 2021 | 1,307 | 3,887 | $694,292 | $60,671 | 8.7% |
| 84166 | Protein measurement, body fluid | Facility | 2021 | 535 | 717 | $120,288 | $11,336 | 9.4% |
| 86335 | Immunologic analysis technique on body fluid, other fluids with concentration | Facility | 2021 | 292 | 454 | $81,464 | $7,334 | 9.0% |
| 83020 | Hemoglobin analysis and measurement, electrophoresis | Facility | 2021 | 91 | 94 | $17,108 | $1,426 | 8.3% |
| 84165 | Protein measurement, serum | Facility | 2020 | 1,524 | 3,983 | $724,906 | $62,727 | 8.7% |
| 86334 | Immunologic analysis technique on serum | Facility | 2020 | 1,040 | 3,282 | $544,812 | $52,267 | 9.6% |
| 84166 | Protein measurement, body fluid | Facility | 2020 | 391 | 523 | $95,186 | $8,460 | 8.9% |
| 86335 | Immunologic analysis technique on body fluid | Facility | 2020 | 214 | 317 | $52,622 | $5,118 | 9.7% |
| 83020 | Hemoglobin analysis and measurement | Facility | 2020 | 93 | 97 | $17,654 | $1,606 | 9.1% |
About Dr. Theodore Kurtz, M.D
Dr. Theodore Kurtz, M.D is a Anatomic Pathology & Clinical Pathology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497797443.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Theodore Kurtz, M.D has received a total of $38,937 in payments from pharmaceutical and medical device companies, with $63.39 received in 2018. These payments were reported across 17 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($13,750).
As a Medicare-enrolled provider, Kurtz has provided services to 16,557 Medicare beneficiaries, totaling 40,391 services with total Medicare billing of $621,650. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location San Francisco, CA
- Active Since 06/12/2006
- Last Updated 06/10/2008
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1497797443
Products in Payments
- MICARDIS (Drug) $25,923
- Repatha (Biological) $8,319
- Procalcitonin (PCT) (Device) $63.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in San Francisco
Jonathan Katz, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $354,080
Dr. Georgios Deftereos, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $56,722
Ronald Balassanian, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $16,950
Dr. Sanjay Kakar, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $14,272
Dr. Dean Fong, Do, DO
Anatomic Pathology & Clinical Pathology — Payments: $752.52
Dr. Enrique Terrazas, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $241.52